AU2001245396A1 - Hb7-h2, a novel co-stimulatory molecule - Google Patents

Hb7-h2, a novel co-stimulatory molecule

Info

Publication number
AU2001245396A1
AU2001245396A1 AU2001245396A AU4539601A AU2001245396A1 AU 2001245396 A1 AU2001245396 A1 AU 2001245396A1 AU 2001245396 A AU2001245396 A AU 2001245396A AU 4539601 A AU4539601 A AU 4539601A AU 2001245396 A1 AU2001245396 A1 AU 2001245396A1
Authority
AU
Australia
Prior art keywords
novel
stimulatory molecule
stimulatory
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245396A
Inventor
Lieping Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Foundation for Medical Education and Research
Original Assignee
Mayo Foundation for Medical Education and Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research filed Critical Mayo Foundation for Medical Education and Research
Publication of AU2001245396A1 publication Critical patent/AU2001245396A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464496—Fusion proteins originating from gene translocation in cancer cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
AU2001245396A 2000-03-02 2001-03-02 Hb7-h2, a novel co-stimulatory molecule Abandoned AU2001245396A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18651900P 2000-03-02 2000-03-02
US60186519 2000-03-02
PCT/US2001/006769 WO2001064704A1 (en) 2000-03-02 2001-03-02 hB7-H2, A NOVEL CO-STIMULATORY MOLECULE

Publications (1)

Publication Number Publication Date
AU2001245396A1 true AU2001245396A1 (en) 2001-09-12

Family

ID=22685267

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245396A Abandoned AU2001245396A1 (en) 2000-03-02 2001-03-02 Hb7-h2, a novel co-stimulatory molecule

Country Status (2)

Country Link
AU (1) AU2001245396A1 (en)
WO (1) WO2001064704A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (en) 1997-02-27 2004-04-19 日本たばこ産業株式会社 Cell surface molecules that mediate cell-cell adhesion and signal transduction
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
US8624010B1 (en) 1999-02-03 2014-01-07 Steven K. Yoshinaga Nucleic acids encoding B7RP1
SI2332976T1 (en) 1999-02-03 2014-08-29 Amgen Inc. Novel polypeptides involved in immune response
US7708993B2 (en) 1999-02-03 2010-05-04 Amgen Inc. Polypeptides involved in immune response
JP3871503B2 (en) 1999-08-30 2007-01-24 日本たばこ産業株式会社 Immune disease treatment
JP4210454B2 (en) 2001-03-27 2009-01-21 日本たばこ産業株式会社 Inflammatory bowel disease treatment
JP3597140B2 (en) 2000-05-18 2004-12-02 日本たばこ産業株式会社 Human monoclonal antibody against costimulatory molecule AILIM and pharmaceutical use thereof
US20040152156A1 (en) * 2001-01-04 2004-08-05 Jeffrey Encinas Regulation of human b7-h2 protein
JP4212278B2 (en) 2001-03-01 2009-01-21 日本たばこ産業株式会社 Graft rejection inhibitor
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1
JOP20140087B1 (en) 2013-03-13 2021-08-17 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof

Also Published As

Publication number Publication date
WO2001064704A1 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU2001239423A1 (en) Catalysts
AU2002218266A1 (en) Novel indanylidene compounds
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2001292518A1 (en) Novel compounds
AU2001239765A1 (en) Novel compounds
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001245396A1 (en) Hb7-h2, a novel co-stimulatory molecule
AU2001246998A1 (en) Novel compounds
AU2001253362A1 (en) Novel compounds
AU6594401A (en) 6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
AU2002245107A1 (en) Improved biochip
AU2001256964A1 (en) Novel compounds
AU2001230689A1 (en) Novel compounds
AU6901201A (en) Tube-filling machine
AU2002216060A1 (en) Novel compounds
AU2001236777A1 (en) 39406 protein, a seven transmembrane protein
AU2001276890A1 (en) Novel compounds
AUPQ484599A0 (en) Reciprocating mechanism
AU2001258760A1 (en) Novel thiophenamide compounds
AU2001237533A1 (en) Novel p-gp-inhibiting compounds
AU2001274750A1 (en) Novel beta-hydroxyamides
AU2001232568A1 (en) Novel compounds
AUPP929799A0 (en) A novel molecule
AU2001236799A1 (en) 18057 protein, a seven transmembrane protein
AU2001256791A1 (en) 5,6-trans-2-alkylvitamin d derivatives